Publications by authors named "Austin G Doyle"

Claim this Profile
A
A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer.
Dustin A Deming, Ludmila L Cavalcante, Sam J Lubner, Daniel L Mulkerin, Noelle K LoConte, Austin G Doyle

Invest New Drugsยท April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis